The Society for Immunotherapy of Cancer (SITC) hosted "Session 303: Hot Topic Symposium: When Phase III Trial Results Diverge from Phase II Data – An Analysis of Recent Trials in Immuno-Oncology" during the 37th Annual Meeting & Pre-Conference Programs on November 12, 2022. Available here are the presentation slides and video from the session, as permitted by presenters.
The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.To view the entire program schedule (including presenter permission to post) please click here.
This library resource entry requires a SITC CONNECT account. Click the Sign In button at the top of this page, otherwise click here to create a FREE SITC CONNECT.
With a free SITC CONNET account, you can begin accessing hundreds of cancer immunotherapy resources in the SITC CONNECT Archive and Resource Libraries. Once your account is created, return to this page, refresh, and a download link should appear.
The SITC connectED education portal is supported by independent educational grants from AstraZeneca Pharmaceuticals LP and Merck & Co., Inc.
Join
Renew
Member Directory
My Profile
Volunteer
Support SITC
Job Board
Contact Us